Qualio, a San Francisco, CA-based cloud quality management system software for the entire life sciences ecosystem, raised $50m in Series B funding round.
The round was led by Tiger Global with participation from Menlo Ventures and current investors Frontline Ventures, MHS Capital, Operator Partners, Sorenson Ventures, and Storm Ventures.
The company, which has raised more than $63m to date, intends to use the funds to expand accessibility of their electronic quality management software (eQMS) and services for life sciences customers at global scale and invest in product and engineering team growth.
Led by Robert Fenton, Founder and CEO, Qualio is a cloud-based quality management software for teams launching and scaling life-saving products.
With more than 250 life sciences customers worldwide, including pharmaceutical, biotech, medical device, and clinical research organizations, use the company’s quality management system software to unite their teams’ processes and data and manage critical quality processes across their entire supply chain.
Customers include notable organizations such as Medable, Paula’s Choice Skincare, Proscia, and Ginkgo Bioworks.